StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Skinvisible's EPS for the twelve months ending Jun 30, 2026 was -$0.20. For fiscal 2024 it was -$0.11. The highest annual figure on record is $0.01 in fiscal 2018.

Annual eps

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$0.11–
FY2023Dec 31, 2023-$0.52–
FY2022Dec 31, 2022-$0.27–
FY2021Dec 31, 2021-$0.24–
FY2020Dec 31, 2020-$0.32–
FY2019Dec 31, 2019-$0.59-6000.0%
FY2018Dec 31, 2018$0.01–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.05–
Q1 FY2026Mar 31, 2026-$0.05–
Q4 FY2025Dec 31, 2025-$0.05-200.0%
Q3 FY2025Sep 30, 2025-$0.05–
Q2 FY2025Jun 30, 2025-$0.05–
Q1 FY2025Mar 31, 2025-$0.05–
Q4 FY2024Dec 31, 2024$0.05–
Q3 FY2024Sep 30, 2024-$0.06–
Q2 FY2024Jun 30, 2024-$0.07–
Q1 FY2024Mar 31, 2024-$0.06–
Q4 FY2023Dec 31, 2023-$0.07–
Q3 FY2023Sep 30, 2023-$0.06–
Q2 FY2023Jun 30, 2023-$0.06–
Q1 FY2023Mar 31, 2023-$0.33–
Q4 FY2022Dec 31, 2022-$0.09–
Q3 FY2022Sep 30, 2022-$0.09–
Q4 FY2021Dec 31, 2021-$0.04–
Q3 FY2021Sep 30, 2021-$0.04–
Q2 FY2021Jun 30, 2021-$0.06–
Q1 FY2021Mar 31, 2021-$0.10–
Q4 FY2020Dec 31, 2020-$0.06–
Q3 FY2020Sep 30, 2020-$0.09–
Q2 FY2020Jun 30, 2020-$0.07–
Q1 FY2020Mar 31, 2020-$0.10–
Q4 FY2019Dec 31, 2019-$0.15-850.0%
Q3 FY2019Sep 30, 2019-$0.12–
Q2 FY2019Jun 30, 2019-$0.21–
Q1 FY2019Mar 31, 2019-$0.12–
Q3 FY2018Sep 30, 2018$0.02–
Q4 FY2017Dec 31, 2017-$0.04–
Q3 FY2017Sep 30, 2017-$0.21–
Q2 FY2017Jun 30, 2017-$0.26–
Q1 FY2017Mar 31, 2017-$0.19–
Q4 FY2016Dec 31, 2016-$0.20–
Q3 FY2016Sep 30, 2016-$0.21–
Q2 FY2016Jun 30, 2016-$0.20–

More Skinvisible figures

See a number that looks wrong?